An2 Therapeutics, Inc. (ANTX)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

5

0

6

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Mar-24 7:27 PM View:	15-Mar-24 Grant 0	Chanda Sanjay Chief Development Officer		An2 Therapeutics, Inc. - ANTX	3741% 0.73K to 28.23K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 7:26 PM View:	15-Mar-24 Grant 0	Easom Eric Chief Executive Officer Director		An2 Therapeutics, Inc. - ANTX	8% 1.21M to 1.31M	0	0	--	--	Show Txns Hide Txns

18-Mar-24 7:29 PM View:	15-Mar-24 Grant 0	Day Lucy Chief Financial Officer		An2 Therapeutics, Inc. - ANTX	879% 3.13K to 30.63K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 7:27 PM View:	15-Mar-24 Grant 0	Eckburg Paul Chief Medical Officer		An2 Therapeutics, Inc. - ANTX	140% 21.42K to 51.42K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 7:28 PM View:	15-Mar-24 Grant 0	Krause Kevin Michael Chief Strategy Officer		An2 Therapeutics, Inc. - ANTX	1567% 1.91K to 31.91K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 7:28 PM View:	15-Mar-24 Grant 0	Eizen Joshua M Chief Legal Officer		An2 Therapeutics, Inc. - ANTX	1226% 2.45K to 32.45K	0	0	--	--	Show Txns Hide Txns